Back to search

Denmark· DK-28103992006

Hiprabovis Somni-Lkt

A inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia vaccines) product, registered in Denmark by Laboratorios Hipra S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC QI02AB

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedHiprabovis Somni-LktATCQI02ABREGISTER NO.DK-28103992006PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Hiprabovis is registered in 2 of 19 countries.

Countries holding a registration under ATC QI02AB (inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia vaccines)), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose

Hiprabovis · ATC QI02AB

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Manufacturer
Laboratorios Hipra S.A.
Country
Denmark (DK)
ATC code
QI02AB
ATC class
Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103992006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QI02AB

Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia vaccines), as other registers publish it.

All Hiprabovis products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db57d8ad-b6f0-42bc-9abb-a891dcc57006
GET /v1/drugs/db57d8ad-b6f0-42bc-9abb-a891dcc57006?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, emulsion",
  "source": "dkma",
  "strength": "7672",
  "auth_role": "CMS",
  "dk_drugid": "28103992006",
  "substance": null,
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "39107"
}

See everything about Hiprabovis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.